Abstract Moenomycins are phosphoglycolipid antibiotics notable for their extreme potency, unique mode of action, and proven record of use in animal nutrition without selection for resistant microflora. There is a keen interest in manipulation of structures of moenomycins in order to better understand their structure-activity relationships and to generate improved analogs. Only two almost identical moenomycin biosynthetic gene clusters are known, limiting our knowledge of the evolution of moenomycin pathways and our ability to genetically diversify them. Here, we report a novel gene cluster (tchm) that directs production of the phosphoglycolipid teichomycin in Actinoplanes teichomyceticus. Its overall genetic architecture is significantly different from that of the moenomycin biosynthesis (moe) gene clusters of Streptomyces ghanaensis and Streptomyces clavuligerus, featuring multiple gene rearrangements and two novel structural genes. Involvement of the tchm cluster in teichomycin biosynthesis was confirmed via heterologous co-expression of amidotransferase tchmH5 and moe genes. Our work sets the background for further engineering of moenomycins and for deeper inquiries into the evolution of this fascinating biosynthetic pathway.
Introduction
Moenomycins (Fig. 1 ) are phosphoglycolipid natural products that directly target peptidoglycan glycosyltransferases involved in the penultimate step of bacterial cell wall biosynthesis (Kahne et al. 2005; Ostash and Walker 2010a) . Despite decades of use as animal growth promoters, there have been no reports on significant resistance to moenomycins (Pfaller 2006) . Uniqueness of their structures, mode of action, and extremely high potency against major Gram-positive pathogens (including MRSA and VRE strains) have attracted attention to them as a model to develop new antibacterial drugs (Lovering et al. 2007; Yuan et al. 2008; Tseng et al. 2014) . It is necessary to explore chemical space around the moenomycin scaffold in order to better understand structure-activity relationships and, eventually, to develop improved analogs. Recently, robust chemical tools to manipulate moenomycin have been developed (Taylor et al. 2006; Adachi et al. 2006; Gampe et al. 2013 ), which are supported by an understanding of the molecular mechanisms of moenomycin A action (Yuan et al. 2008; Gampe et al. 2011) . Although new molecules can be produced through chemical synthesis, this approach does not provide rapid access to a range of molecules (Ostash et al. 2010b) . Novel moenomycins obtained through biosynthesis would be invaluable as starting materials for chemical Liliya Horbal and Bohdan Ostash equally contributed. Electronic supplementary material The online version of this article (doi:10.1007/s00253-016-7685-3) contains supplementary material, which is available to authorized users. * Liliya Horbal lihorbal@gmail.com manipulations and biological evaluation. The biosynthetic approach hinges on the availability of diverse collections of genes, whose combinatorial expression would lead to novel phosphoglycolipids. However, only two almost identical moenomycin biosynthesis gene clusters (moe) have been described so far, in Streptomyces ghanaensis ATCC14672 (Ostash et al. 2009 ) and Streptomyces clavuligerus ATCC27064 (Song et al. 2010) , limiting the prospects for novel moenomycins via biosynthesis. This fact prompted us to turn our attention to Actinoplanes teichomyceticus, which was described in late 1970s as a producer of two distinct groups of antibiotics: teichomycins A1 and A2. Teichomycin A1 (TeiA) complex was shown to fall into moenomycin family of antibiotics (Bardone et al. 1978; Borghi et al. 1984) , while teichomycin A2 turned out to be a mixture of lipoglycopeptide metabolites known today as teicoplanin (Pryka et al. 1988; Li et al. 2004; Sosio et al. 2004; Horbal et al. 2014) . From limited chemical degradation experiments (Bardone et al. 1978; Borghi et al. 1984) , it was inferred that TeiA closely resembles other members of moenomycin family, although the exact structure of TeiA was not established.
Herein, we report identification and characterization of the genes responsible for the production of TeiA by A. teichomyceticus. There is a high similarity between individual genes from tchm and moe clusters, although their overall genetic organization is different. Also, two tchm genes, having no counterparts in the moe cluster, were revealed and are likely involved in moenomycin lipid moiety production. Expression of the amidotransferase gene tchmH5, a homologue of moeH5, in a moeH5-deficient heterologous host confirmed involvement of TchmH5 in moenomycin production and revealed its altered donor substrate specificity. Finally, we provide initial LC-MS-based evidence for the structure of major components of the TeiA complex. Our work offers new opportunities for the biosynthetic derivatization of moenomycins.
Materials and methods

Bacterial strains and growth conditions
The bacterial strains used in this study are listed in Table 1 . Escherichia coli strains were grown in Luria-Bertani (LB) medium, and antibiotics were added to cultures, when required, at the following concentrations per milliliter: ampicillin 65 μg, kanamycin 50 μg, apramycin 50 μg, and hygromycin 120 μg. Medium components and antibiotics were purchased from Sigma-Aldrich (St. Louis, MO, USA).
For conjugation, S. ghanaensis and Streptomyces coelicolor strains were grown on oatmeal or on MS medium for vigorous sporulation (Kieser et al. 2000) . Selection of the exconjugants was performed on the same media supplemented with appropriate antibiotics, when required. For DNA isolation, exconjugants were grown in 25-ml liquid tryptic soy broth (TSB) medium.
Recombinant DNA techniques
Isolation of genomic DNA from S. ghanaensis, S. coelicolor, and A. teichomyceticus, and plasmid DNA from E. coli was carried out using standard protocols (Kieser et al. 2000) . Restriction enzymes and molecular biology reagents were used according to the recommendation of suppliers Thermo Scientific (Schwerte, Germany), Promega (Madison, USA), and NEB (England).
Genome sequencing and annotation
Genome sequencing was performed using an Illumina platform. Small-(300 bp) and large (3000 bp)-insert shotgunsequencing libraries were prepared from high-molecularmass genomic DNA of A. teichomyceticus NRRL-B16726. Reads were assembled using the Newbler assembler v2.6 (Roche). The initial Newbler assembly consisted of 1000 Fig. 1 Structures of moenomycin family antibiotics mentioned in the text. Moenomycin A (MmA) is the founding member of the family contigs in 284 scaffolds. Some of the gaps were closed by primer walking using specially designed PCR primers. Protein coding genes and ribosomal binding sites were identified using Prodigal v2.60 (Hyatt et al. 2010) . For annotation, BLAST searches against the NCBI non-redundant protein database were performed. Non-coding genes were predicted using tRNAscan-SE v1.3.1 and RNAmmer v1.2 (Lowe and Eddy 1997; Lagesen et al. 2007 ).
Identification of the tchm gene cluster
To find the tchm biosynthetic gene cluster in the A. teichomyceticus genome, a search a homologue of the MoeO5 protein was performed. As a result, gene tchmO5 was identified. Comparison of the other genes in the vicinity of tchmO5 to the moe cluster revealed 18 open reading frames (ORFs) that are located on two scaffolds and might be responsible for teichomycin production. These two scaffolds do not overlap. Thus, to fill the gap between them, we performed sequencing of the fragment that was obtained after amplification using primers scaffold51-54Forw and scaffold51-54Rev (Table 2) , one of which was complementary to the end of scaffold 51 and another to scaffold 54. As a result of the analysis, we closed the hole between the two scaffolds and identified all genes that might constitute the tchm cluster. The accession number to the tchm gene cluster sequence is KU726098.
Plasmid construction
A 2.05-kb fragment containing the tchmH5 gene was amplified from the chromosomal DNA of A. teichomyceticus using primers tchmH5Forw and tchmH5Rev (Table 2) , then hydrolyzed with KpnI and EcoRI, and cloned into the respective site of pSETPmoeE5. As a result, plasmid pSETmoeEtchmH5 (Table 1 ) was obtained. A 2.4-kb XbaI/ EcoRI fragment, containing the tchmH5 gene fused with the moeE5p promoter, was retrieved from pSETmoeE5Asp and cloned into the respective site of pOOB47a ). This yielded pOOBPmoetchmH5 (Table 1) .
The apram ycin resistance gene (aac( 3 ) IV) in pOOBPmoetchmH5 was replaced with the hygromycin cassette (pHYG1) that was amplified using primers P1Am-Hygup and P2Am-Hyg-rp (Table 2 ) and the λRed recombination p r o c e s s ( G u s t e t a l . 2 0 0 2 ) . T h i s g a v e p l a s m i d pOOBPmoetchmH5-hyg (Table 1) .
Teichomycin production and analysis
Spores of A. teichomyceticus were grown as a preculture in a liquid seed medium (g/L: glucose 30, yeast extract 5, peptone 5, K 2 HPO 4 4, КН 2 РО 4 2, MgSO 4 ·7H 2 O 0.5, pH 7.2) at 30°C and 200 rpm for 5 days. Three milliliters of the obtained seed broth was used to inoculate 300-ml flasks containing 50 ml of seed medium and was kept growing further for 5 days at 30°C and 200 rpm. The production culture was centrifuged for 10 min at 5000 rpm, supernatant was discarded, and the cell pellets were washed two times with distilled water. TeiA extraction from the cells was performed by stirring them with 10 ml of methanol overnight. After centrifugation at 5000 rpm for 5 min, the supernatant was transferred into a fresh tube and concentrated in vacuo, enriched for moenomycin-like compounds using Waters Sep-Pak C18 SPE cartridge, and subjected to LC/MS analysis. LC/MS experiments were performed using a Phenomenex Gemini 5μ C18 100A column (100 mm × 2.0 mm) at a flow rate of 0.5 ml/min (solvent A: water, 5 mM ammonium formate; solvent B 35:65 water/ acetonitrile modified with 5 mM ammonium formate). Samples were monitored in negative mode on Agilent 6520 LC/QTOF and Bruker Esquire 3000 ESI-MS spectrometers with a linear gradient over 20 min (0-100 % B from 2 to 18 min). Selected mass peaks were subjected to MS/MS experiments as described (Ostash et al. 2007 ).
Moenomycin production and analysis
Spores of S. coelicolor or S. ghanaensis strains, containing plasmids for moenomycin production, were inoculated as seed cultures into liquid TSB medium and were grown for 2 days at 200 rpm and 30°C. Afterward, 5 % of the preculture was inoculated into 300-ml flasks containing 50 ml of TSB medium. Flasks were incubated at 30°C and 220 rpm for 5 days. Moenomycin was extracted from biomass as previously described . Obtained samples were directly used for the LC-MS or MS 2 .
Results
Identification of the teichomycin biosynthetic gene cluster
At the beginning of this project, there were no available gene clusters for moenomycin biosynthesis from nonstreptomycete species and no genome sequences from genus Actinoplanes. We therefore generated draft genome sequence of A. teichomyceticus using Illumina sequencing (for details, see BMaterials and methods^section). As a result, contigs that cover 98 % of the genome were generated. Using several available assemblers, 1000 contigs were composed into 284 scaffolds. The quality was enough to mine for secondary metabolic gene clusters and other genes of interest. We reasoned that TeiA, like all moenomycins, is composed of glycosideand isoprene-derived moieties bridged by 3-phosphoglyceric acid (3-PG) (Bardone et al. 1978; Ostash et al. 2009 ). Thus, TeiA gene cluster should encode a homologue of the MoeO5 protein that catalyzes the first dedicated step in moenomycin biosynthesis-transfer of farnesyl-PP onto a 3-PG moiety (Ostash et al. 2009; Ostash et al. 2007 ). Indeed, we were able to identify a gene, tchmO5, whose translation product showed 55 % identity and 67 % similarity to MoeO5. Further analysis (for details see, BMaterials and methods^section) turned up 18 ORFs in the vicinity of tchmO5, most of which showed varying degree of similarity to genes within moe cluster of S. ghanaensis.
Annotation and analysis of the teichomycin gene cluster
The G+C content of the tchm cluster is 73.4 %, typical for the Actinoplanes genus (Yamamura et al. 2012 ); it did not differ from the overall GC content of A. teichomyceticus NRRL-B16726 genome (72.7 %) and its flanking regions (in average 71.8 %). The putative functions of the predicted ORFs and their similarity to moe clusters from S. ghanaensis and S. clavuligerus are summarized in Table 3 . Out of 18 identified tchm genes, 16 have orthologues in the moe cluster, although the overall genetic architectures of tchm and moe clusters are quite different (Fig. 2) . The tchm cluster lacked homologues of moeA4-B4-C4 genes, those that form moe 2 cluster in S. ghanaensis, and is composed only of a single set of genes that are located on one locus; no putative A-ring biosynthesis genes were found elsewhere in the NRRL-B16726 genome. In addition, there are no homologues of moeB5*, A5*, S5, and R5 in the tchm cluster and there are two extra genes coding for a putative prenylsynthetase (tchmZ) and a prenylcyclase (tchmY). Like the moe cluster, tchm lacks cluster-situated regulatory genes. In contrast to the moe genes, the tchm genes do not contain TTA codons, which are known to limit moenomycin production at the translational level, in their coding sequences (Makitrynskyy et al. 2013) . In general, tRNA Leu UAA (encoded by bldA gene) is an important and widespread regulatory switch in Streptomycetes Chandra and Chater 2008; Liu et al. 2013) . It is likely that the tchm cluster is not subject to direct bldA control.
The tchm cluster encodes proteins involved in isoprenoid metabolism. Namely, TchmO5 and TchmN5 are homologous to prenyltransferases MoeO5 and MoeN5, whose roles in moenomycin biosynthesis are well established (Ostash et al. 2009 ). According to sequence (BLASTP) and structural homology (HHPred) alignment programs, the two others, TchmY and TchmZ, are homologous to isoprenoid biosynthesis enzymes of C2-and C1-like superfamilies, respectively. The former includes prenylcyclases that catalyze a cationic cyclization cascade converting linear prenyl chains to fused ring compounds (Sato 2013) . The representatives of the latter family are known as trans-isoprenyl diphosphate synthases that catalyze head-to-tail (HT) (1′-4) condensation reactions and synthesize various chain length (C10 to C50) linear isoprenyl diphosphates f r o m p r e c u r s o r s i s o p e n t e n y l d i p h o s p h a t e a n d dimethylallyl diphosphate (Wang and Ohnuma 2000) . We therefore suggest that TchmY performs terminal cyclization of the moenocinyl chain in teichomycin, leading to diumycinol chain (Fig. 1, unit z) and, correspondingly, cyclized isomers of moenomycins, such as AC326-α (Ostash and Walker 2010a; Ostash et al. 2010b; He et al. 2000) . The prenylpyrophosphate synthase TchmZ could provide a pool of activated isoprene units specifically for moenomycin production pathway. Almost the entire complement of carbohydrate modification and transfer genes of moe cluster has counterparts in tchm. Notable differences are the absence of genes for the following: (i) conversion of N-acetyl-Dglucosamine (GlcNAc) into chinovosamine (moeR5, moeS5) and (ii) A-ring biosynthesis (moeA4-C4).
The conversion of moenomycins with a free carboxyl group on the terminal galacturonic acid (nosokomycins, Fig. 1 ) into a diverse set of compounds featuring a carboxamide, an A-ring, or amino acids is carried out 
by single glutamine amidotransferase MoeH5 ). There are two putative genes for asparagine synthetase in the tchm cluster, tchmF5, and tchmH5. The translation product of the former is similar to MoeF5, which is involved in carboxyamidation of the first carbohydrate unit in moenomycins. Interestingly, the second protein, TchmH5, resembles MoeF5 and MoeH5 almost to the same degree, implying that duplication of ancestral MoeF5 might be the evolutionary origin of MoeH5 in moenomycin biosynthesis. In comparison to MoeF5 that poses a typical Ntn-type asparaginase domain for glutamine hydrolysis with absolutely conserved cysteine Cys 1 , the Ntn domain of MoeH5 is significantly truncated that is an additional evidence that the latter has evolved from the former . A higher degree of similarity between MoeF5 and TchmF5 indirectly suggests that TchmH5 functions as MoeH5; namely, it controls conversion of nosokomycin into final products. Both TchmH5 and TchmF5 contain an N-terminal Ntn-type asparaginase domain for glutamine hydrolysis and a Cterminal AsnB-like asparagine synthetase domain. All conserved amino acids, including the Cys1 residue absolutely required for activity, are present in the Ntn domain of TchmH5 and TchmF5 (Fig. S1 ). Thus, both TchmF5 and TchmH5 proteins appear to be typical glutamine amidotransferases that can use only glutamine as an amide nitrogen donor to transfer to the appropriate moenomycin intermediate (Zalkin 1993; Zalkin and Smith 1998) . In contrast, MoeH5 contains a truncated N-domain conferring this enzyme with the ability to use a wider set of amide donor substrates . The tchm gene cluster, similarly to the moe cluster, contains four genes for two putative ABC transport systems that might be involved in moenomycin production or extrusion.
Overexpression of tchmH5 in S. ghanaensis dH5 and S. coelicolor M1152 moeno 38-6 + .
Our initial bioinformatic analysis (vide supra) pointed to the possibility that TchmH5 can be involved in the last step of teichomycin biosynthesis and it may have narrower donor substrate specificity compared to MoeH5. To test this hypothesis, we attempted to complement moeH5 deficiency in two strains, namely S. ghanaensis dH5 ) and S. coelicolor M1152 moeno 38-6 + , with the tchmH5 gene (Lopatniuk et al. 2014) . The dH5 and M1152 moeno 38-6 + strains accumulated nosokomycin A and A2, respectively, as the final products of the moenomycin pathway (Fig. 1) .
For the complementation experiments, we constructed plasmids pOOBPmoetchmH5 and pOOBPmoetchmH5-hyg (Table 1) , where tchmH5 was placed under the control of the NDP-hexose epimerase gene moeE5 promoter (moeE5p) (Horbal et al. 2013) . The pOOBPmoetchmH5 and pOOBPmoetchmH5-hyg were transferred into S. coelicolor M1152 moeno 38-6 + and S. ghanaensis dH5, respectively. We assessed moenomycin production in the recombinants and compared it to the control strains. LC-MS analysis of extracts from S. Fig. 2 Genetic organization of the teichomycin (tchm) biosynthetic gene cluster of A. teichomyceticus and its comparison with moenomycin (moe) gene clusters. Homologues in the tchm and moe clusters are attached with lines and tchm genes that do not have counterparts in the moe cluster are denoted with red color (Color figure online) had a molecular mass of 1500.6 Da and HPLC retention time similar to that of nosokomycin B 2 (Fig. 3a) . MS/MS analysis of m/z 1500.6 detected several characteristic mass peaks routinely observed during fragmentation of moenomycins (Fig. S2) . Therefore, based on HPLC mobility, molecular mass, and fragmentation data, we postulate that this compound is nosokomycin B 2 . We detected no mass peaks that would correspond to glycine-or other amino acid-decorated moenomycins in M1152 38-6 + pOOBmoetchmH5 + extracts. These data are in agreement with the suggestion that TchmH5 can produce only carboxamide in the presence of ammonia and nosokomycin (Fig. 3b) .
We have found no new compounds in the extracts of S. ghanaensis dH5 carrying pOOBPmoetchmH5-hyg, although the parental compound to be converted by TchmH5, nosokomycin A, was abundantly produced. At this point, we cannot explain why TchmH5 did not convert nosokomycin A into its carboxamide form, nosokomycin B, as it did in the heterologous host strain M1152 38-6 + , which produced nosokomycin A 2 . The latter differs from nosokomycin A in its C-ring, which comes in the form of a GlcNAc residue in nosokomycin A 2 , and as chinovosamine (Chi), a reduced version of GlcNAc, in nosokomycin A. Although a minor difference, this may account for the inability of TchmH5 to recognize nosokomycin A as an acceptor substrate. This suggestion is in line with the fact that the tchm cluster lacks homologues of moeR5 and S5 genes, which are involved in the conversion of UDP-GlcNAc into UDP-Chi (Ostash et al. 2009 ). Our experimental finding may reflect extensive co-evolution of different stages of the teichomycin pathway, so that downstream enzymes are able to accept only certain substrates.
A. teichomyceticus produces moenomycins
Guided by the bioinformatic analysis as well as results of the tchmH5 heterologous expression, we suggested that A. teichomyceticus should accumulate, as a major compound, either nosokomycin B 2 or its derivative with a diumycinol chain (see Fig. 1 for the structures). Indeed, careful LC-MS analysis of the biomass extracts showed that the strain accumulated a compound with molecular mass of 1500.6 Da (Fig.  4) . Its chromatographic mobility, collision induced dissociation (CID) pattern (see Fig. S3 ), and accurate mass (calcd 1500.6278; obsvd 1500.6263) are consistent with the structure of known member of the moenomycin family NoB 2 or its diumycinol-carrying derivative. We observed two other moenomycin-like products in the extracts. The first one corresponds to NoA 2 or its diumycinol-carrying derivative (accurate mass: calcd 1501.6118; obsvd 1501.6105; see also Fig.  S4 ), a precursor of the 1500.6 Da compound featuring a free carboxyl group on its B-ring and 1484.6 Da. The second one had LC mobility, accurate mass (calcd 1484.6329; obsvd 1484.6344), and a CID pattern (Fig. S5 ) consistent with the structure of nosokomycin B or its diumycinol-bearing derivative. The major product of 1500.6 Da NoB 2 and NoB differs in the structure of their C-rings, which is N-acetylglucosamine (GlcNAc) in the former, while the latter carries its reduced form, Chi. It was rather unexpected to observe NoB in Actinoplanes techomyceticus extracts, since the tchm cluster evidently has no genes (homologous to moeR5 and moeS5) for conversion of GlcNAc into Chi. Nevertheless, we previously observed production of Chi-bearing moenomycins in the absence of a moeR5moeS5 gene pair in the heterologous strain Streptomycetes lividans (Ostash et al. 2007) . Probably, there are moeR5moeS5 homologues elsewhere in A. techomyceticus genome, that could, with low efficiency, lead to the production of Chi. We also note that the production level of the compound with molecular mass 1484.6 Da is much lower as compared to major expected product with mass 1500.6 Da (see Fig. 4) . No other moenomycin-like compounds were detected in the extracts. In spite of extensive experimentation with fermentation conditions, the production of nosokomycin B 2 (or its cyclized isomer) was either too low or too irreproducible to obtain reasonable quantities for NMR analysis and verification of the structure of the lipid chain.
Discussion
Pathogenic bacteria in both clinical and community settings are a major global health problem of humankind (Paphitou 2013; Fair and Tor 2014) . Nowadays, it is obvious that the emergence of the resistance to a new antibiotic introduced into a wide use is inevitable and, in most cases, that is only a matter of time. Therefore, there is an urgent and permanent need in new drugs, especially antibiotics that have new modes of action and uncommon targets. Moenomycins are representatives of a small group of phosphoglycolipids that act through direct inhibition of peptidoglycan glycosyltransferases (PGTs) involved in bacterial cell wall formation and are active against vancomycin-and methicillin-resistant Gram-positive pathogens (Ostash and Walker 2010a) . Despite that they are widely used in animal nutrition, no resistance to these antibiotics was detected; thus, they represent a group of highly active and promising drugs (Pfaller 2006) . Therefore, there is a need to investigate chemical space around this group of antibiotics in order to get new improved analogs.
Herein, we report, for the first time, the identification and experimental verification of the teichomycin biosynthetic gene cluster from A. teichomyceticus. Analysis of the tchm cluster revealed the presence of 18 ORFs, 16 of which have orthologues within the S. ghanaensis moe cluster (Ostash et al. 2009) . Despite a high level of similarity between individual genes within the clusters, their overall genetic organization is strikingly different because of multiple rearrangements and the presence of two additional tchm genes (Fig. 2) . Furthermore, A-ring and chinovosamine biosynthetic moe genes have no counterparts in the tchm cluster. We suggest that the relative simplicity of genetic organization of the latter cluster reflects an ancestral (or at least early) state, which has evolved into a more complex and rearranged pathway encoded by the moe cluster of S. ghanaensis and related Streptomycetes (Ostash et al. 2009; Song et al. 2010) . Comparative analysis of moe and tchm clusters lends several Fig. 1 for structures) . Red arrow indicates peak corresponding to NoA 2 (1501.6 Da) that overlaps with 1501.6 Da isotope of NoB 2 (Color figure online) lines of support to this conjecture. First, unlike the split moe cluster, all tchm genes form a single cluster, which contains fewer genes than the S. ghanaensis moe cluster. Second, there is collinearity between tchm gene organization and the order of participation of respective proteins in TeiA biosynthesis. That is, all tchm genes for early steps of TeiA production (up to trisaccharide; tchmO5-E5-GT1-F5-M5-R5-GT5-G4) are located together, while in the moe cluster, the same genes are interspersed with those involved in later stages of moenomycin synthesis. Finally, the tchm cluster appears not to be subject to direct translational control, which governs moe cluster expression (Makitrynskyy et al. 2013) . At the time of writing of this paper, more Actinoplanes genomes have become available and their screening with the antiSMASH online service revealed a tchm gene cluster in the genome of Actinoplanes subtropicus as well.
The involvement of the tchm locus in TeiA biosynthesis was confirmed via heterologous expression of the tchmH5 amidotransferase gene. Furthermore, we revealed that the substrate specificity of TchmH5 is different from that of MoeH5. Namely, while the latter is capable of transferring amide donor groups as diverse as ammonia, A-ring, and glycine ), TchmH5 catalyzes only carboxyamidation using glutamine as an amide nitrogen donor; it appears to recognize only a certain type of acceptor substrate, that is, NoA 2 (Fig.  3b) . TchmH5 would be an interesting tool in the context of experiments aimed to simplify the composition of moenomycins produced by S. ghanaensis. Finally, in this work, we provided initial clues about the structure of principal components of the TeiA complex. Taking into account the tchm cluster analysis and LC-MS data, we suppose that TeiA, in fact, is either nosokomycin B 2 or its derivative carrying a diumycinyl instead of a moenocinyl chain. Summing up the obtained data, we anticipate that characterization and further study of the tchm genes open the way for genetic manipulations of the cluster to obtain moenomycins with improved biological properties.
